歯周治療法の世界市場:局所抗生物質、全身抗生物質

◆英語タイトル:Global Periodontal Therapeutics Market 2019-2023
◆商品コード:IRTNTR31411
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年6月19日
◆ページ数:123
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、歯周治療法の世界市場について調べ、歯周治療法の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、歯周治療法の市場規模をセグメンテーション別(製品別(局所抗生物質、全身抗生物質))と地域別(グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ))に分けて算出しました。
・サマリー
・レポートの範囲
・歯周治療法の市場状況
・歯周治療法の市場規模
・歯周治療法の市場予測
・歯周治療法の世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(局所抗生物質、全身抗生物質)
・歯周治療法の顧客状況
・主要地域別市場規模:グローバル、米州、アジア太平洋、EMEA(ヨーロッパ・中東・アフリカ)
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

About this Market

Periodontal diseases are prevalent in both developed and developing countries across the world. The disease affects individuals regardless of their age and has become one of the growing public health concerns. The disease is common among individuals in developing countries compared to developed countries. Globally, it is posing as one of the most common oral conditions in human being. The rising prevalence of periodontal diseases across the world will increase the demand for periodontal drugs and subsequently drive the growth of the global periodontal therapeutics market size at a CAGR of over 6% during the forecast period.

Market Overview

Changing lifestyle

Poor oral hygiene, stress, diabetes, smoking, and other age-related risk factors are some of the negative aspects of a fast-changing lifestyle. These factors increase the probability of the onset of periodontal diseases. This is expected to have a positive impact on the growth of the global periodontal therapeutics market size.

Lack of awareness about disease symptoms and cure

There is a delay in the diagnosis and treatment for periodontal disease due to the lack of awareness about the symptoms associated with periodontal diseases. Despite its high prevalence, only a small proportion of the affected population seek medical treatment. This is expected to hinder the growth of the market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the periodontal therapeutics market size during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated with few players occupying the market share. Companies such as 3M Co. and Bausch Health Companies Inc. have intensified competition. Factors such as the growing prevalence of periodontal diseases and the changing lifestyle of people will provide significant growth opportunities for periodontal therapeutics companies. 3M Co., Bausch Health Companies Inc., Den-Mat Holdings LLC, Kaken Pharmaceuticals Co. Ltd., and Teva Pharmaceutical Industries Ltd. are some of the major companies covered in this report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Local antibiotics – Market size and forecast 2018-2023

Systemic antibiotics – Market size and forecast 2018-2023

Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 14: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

3M Co.

Bausch Health Companies, Inc.

Den-Mat Holdings LLC

Kaken Pharmaceuticals Co. Ltd.

Teva Pharmaceutical Industries Ltd.

PART 15: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

Exhibit 01: Global oral hygiene products market

Exhibit 02: Segments of global oral hygiene products market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Market definition – Inclusions and exclusions checklist

Exhibit 06: Market size 2018

Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 09: Five forces analysis 2018

Exhibit 10: Five forces analysis 2023

Exhibit 11: Bargaining power of buyers

Exhibit 12: Bargaining power of suppliers

Exhibit 13: Threat of new entrants

Exhibit 14: Threat of substitutes

Exhibit 15: Threat of rivalry

Exhibit 16: Market condition – Five forces 2018

Exhibit 17: Pipeline landscape for periodontal diseases

Exhibit 18: Some of the key clinical trials for periodontal diseases

Exhibit 19: Product – Market share 2018-2023 (%)

Exhibit 20: Comparison by product

Exhibit 21: Local antibiotics – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Local antibiotics – Year-over-year growth 2019-2023 (%)

Exhibit 23: Systemic antibiotics – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Systemic antibiotics – Year-over-year growth 2019-2023 (%)

Exhibit 25: Market opportunity by product

Exhibit 26: Customer landscape

Exhibit 27: Market share by geography 2018-2023 (%)

Exhibit 28: Geographic comparison

Exhibit 29: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 30: North America – Year-over-year growth 2019-2023 (%)

Exhibit 31: Top 3 countries in North America

Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 33: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 34: Top 3 countries in Europe

Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 37: Top 3 countries in Asia

Exhibit 38: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 39: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 40: Top 3 countries in ROW

Exhibit 41: Key leading countries

Exhibit 42: Market opportunity

Exhibit 43: Risk factors for periodontal diseases

Exhibit 44: Impact of drivers and challenges

Exhibit 45: Percent of periodontal disease with age

Exhibit 46: Vendor landscape

Exhibit 47: Landscape disruption

Exhibit 48: Vendors covered

Exhibit 49: Vendor classification

Exhibit 50: Market positioning of vendors

Exhibit 51: 3M Co. – Vendor overview

Exhibit 52: 3M Co. – Business segments

Exhibit 53: 3M Co. – Organizational developments

Exhibit 54: 3M Co. – Geographic focus

Exhibit 55: 3M Co. – Segment focus

Exhibit 56: 3M Co. – Key offerings

Exhibit 57: 3M Co. – Key customers

Exhibit 58: Bausch Health Companies Inc. – Vendor overview

Exhibit 59: Bausch Health Companies Inc. – Product segments

Exhibit 60: Bausch Health Companies Inc. – Organizational developments

Exhibit 61: Bausch Health Companies Inc. – Geographic focus

Exhibit 62: Bausch Health Companies Inc. – Segment focus

Exhibit 63: Bausch Health Companies Inc. – Key offerings

Exhibit 64: Bausch Health Companies Inc. – Key customers

Exhibit 65: Den-Mat Holdings LLC – Vendor overview

Exhibit 66: Den-Mat Holdings LLC – Business segments

Exhibit 67: Den-Mat Holdings LLC – Organizational developments

Exhibit 68: Den-Mat Holdings LLC – Key offerings

Exhibit 69: Den-Mat Holdings LLC – Key customers

Exhibit 70: Kaken Pharmaceuticals Co. Ltd. – Vendor overview

Exhibit 71: Kaken Pharmaceuticals Co. Ltd. – Business segments

Exhibit 72: Kaken Pharmaceuticals Co. Ltd. – Organizational developments

Exhibit 73: Kaken Pharmaceuticals Co. Ltd. – Segment focus

Exhibit 74: Kaken Pharmaceuticals Co. Ltd. – Key offerings

Exhibit 75: Kaken Pharmaceuticals Co. Ltd. – Key customers

Exhibit 76: Teva Pharmaceutical Industries Ltd. – Vendor overview

Exhibit 77: Teva Pharmaceutical Industries Ltd. – Business segments

Exhibit 78: Teva Pharmaceutical Industries Ltd. – Organizational developments

Exhibit 79: Teva Pharmaceutical Industries Ltd. – Geographic focus

Exhibit 80: Teva Pharmaceutical Industries Ltd. – Segment focus

Exhibit 81: Teva Pharmaceutical Industries Ltd. – Key offerings

Exhibit 82: Teva Pharmaceutical Industries Ltd. – Key customers

Exhibit 83: Validation techniques employed for market sizing

Exhibit 84: Definition of market positioning of vendors



【掲載企業】

3M Co.、Bausch Health Companies Inc.、Den-Mat Holdings LLC、Kaken Pharmaceuticals Co. Ltd.、Teva Pharmaceutical Industries Ltd.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[歯周治療法の世界市場:局所抗生物質、全身抗生物質]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆